ASH 2020: The Anti-Tumor Activity of IGM-8444, an Agonistic Death Receptor 5 (DR5) IgM Antibody, is Sensitized in Combination with Chemotherapy and Bcl-2 Inhibitors in NHL and AML

62nd American Society of Hematology (ASH) Annual Meeting and Exposition – December 5-8, 2020 – Session: 625. Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents